DrugDashboards

Tofacitinib

tofacitinib · TOFACITINIB 10 mg/1 · Tablet, Film Coated · Oral · Apotex Corp.

NDC 60505-6264-05 · 500 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

12 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for tofacitinib (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA218096
TE code
AB
Approval date
Jun 3, 2026
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of tofacitinib (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Apotex Corp.TOFACITINIB 10 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.TOFACITINIB 5 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedTOFACITINIB CITRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedTOFACITINIB CITRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedTOFACITINIB CITRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedTOFACITINIB CITRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Micro Labs LimitedTOFACITINIB CITRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Micro Labs LimitedTOFACITINIB CITRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCTOFACITINIB CITRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCTOFACITINIB CITRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Laboratories Div Pfizer IncTOFACITINIB CITRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Laboratories Div Pfizer IncTOFACITINIB CITRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCTOFACITINIB CITRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCTOFACITINIB CITRATE 10 mg/1Jul 15, 2026Sep 2, 2026
U.S. PharmaceuticalsTOFACITINIB CITRATE 10 mg/1Jul 15, 2026Sep 2, 2026
U.S. PharmaceuticalsTOFACITINIB CITRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedTOFACITINIB CITRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedTOFACITINIB CITRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.TOFACITINIB CITRATE 5 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.TOFACITINIB CITRATE 10 mg/1Jul 15, 2026Sep 2, 2026
AvKARETOFACITINIB CITRATE 5 mg/1Jul 25, 2026Aug 29, 2026
AvKARETOFACITINIB CITRATE 10 mg/1Jul 25, 2026Aug 29, 2026
Golden State Medical Supply, Inc.TOFACITINIB 5 mg/1Aug 15, 2026Aug 29, 2026
Golden State Medical Supply, Inc.TOFACITINIB 10 mg/1Aug 15, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tofacitinib — NDC 60505-6264-05," retrieved September 3, 2026, https://drugdashboards.com/drug/60505626405.

Free to cite with attribution — see how the data is put together.